Ballentine Partners’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.85M | Buy |
6,703
+1,575
| +31% | +$445K | 0.02% | 240 |
|
|
2026
Q1 | $1.37M | Sell |
5,128
-1,425
| -22% | -$394K | 0.02% | 282 |
|
|
2025
Q4 | $1.8M | Sell |
6,553
-2,975
| -31% | -$834K | 0.03% | 208 |
|
|
2025
Q3 | $2.75M | Buy |
9,528
+99
| +1% | +$29.3K | 0.04% | 154 |
|
|
2025
Q2 | $3.12M | Buy |
9,429
+1,463
| +18% | +$472K | 0.05% | 136 |
|
|
2025
Q1 | $2.62M | Buy |
7,966
+1,383
| +21% | +$417K | 0.05% | 148 |
|
|
2024
Q4 | $1.82M | Sell |
6,583
-1,143
| -15% | -$364K | 0.03% | 190 |
|
|
2024
Q3 | $2.68M | Buy |
7,726
+691
| +10% | +$238K | 0.05% | 139 |
|
|
2024
Q2 | $2.33M | Sell |
7,035
-985
| -12% | -$340K | 0.04% | 140 |
|
|
2024
Q1 | $2.91M | Buy |
8,020
+1,070
| +15% | +$352K | 0.06% | 115 |
|
|
2023
Q4 | $2.08M | Buy |
6,950
+1,740
| +33% | +$508K | 0.04% | 139 |
|
|
2023
Q3 | $1.49M | Buy |
5,210
+333
| +7% | +$95K | 0.04% | 152 |
|
|
2023
Q2 | $1.37M | Buy |
4,877
+1,231
| +34% | +$321K | 0.03% | 161 |
|
|
2023
Q1 | $932K | Sell |
3,646
-341
| -9% | -$99.4K | 0.02% | 206 |
|
|
2022
Q4 | $1.32M | Buy |
3,987
+515
| +15% | +$163K | 0.04% | 144 |
|
|
2022
Q3 | $963K | Buy |
3,472
+801
| +30% | +$225K | 0.03% | 161 |
|
|
2022
Q2 | $704K | Buy |
2,671
+82
| +3% | +$21.1K | 0.02% | 191 |
|
|
2022
Q1 | $621K | Buy |
2,589
+23
| +0.9% | +$5.38K | 0.02% | 231 |
|
|
2021
Q4 | $589K | Buy |
2,566
+238
| +10% | +$50.6K | 0.02% | 240 |
|
|
2021
Q3 | $466K | Buy |
2,328
+420
| +22% | +$91.3K | 0.02% | 251 |
|
|
2021
Q2 | $452K | Buy |
1,908
+39
| +2% | +$9.74K | 0.02% | 250 |
|
|
2021
Q1 | $451K | Buy |
1,869
+401
| +27% | +$89.4K | 0.02% | 236 |
|
|
2020
Q4 | $306K | Sell |
1,468
-636
| -30% | -$125K | 0.01% | 283 |
|
|
2020
Q3 | $356K | Buy |
2,104
+7
| +0.3% | +$1.23K | 0.02% | 258 |
|
|
2020
Q2 | $394K | Buy |
2,097
+55
| +3% | +$10.4K | 0.02% | 231 |
|
|
2020
Q1 | $362K | Buy |
2,042
+162
| +9% | +$31.4K | 0.02% | 224 |
|
|
2019
Q4 | $384K | Buy |
1,880
+189
| +11% | +$34.7K | 0.02% | 257 |
|
|
2019
Q3 | $257K | Buy |
1,691
+6
| +0.4% | +$976 | 0.01% | 313 |
|
|
2019
Q2 | $266K | Sell |
1,685
-24
| -1% | -$3.76K | 0.01% | 314 |
|
|
2019
Q1 | $275K | Sell |
1,709
-618
| -27% | -$113K | 0.01% | 257 |
|
|
2018
Q4 | $443K | Buy |
2,327
+1,181
| +103% | +$246K | 0.03% | 196 |
|
|
2018
Q3 | $239K | Buy |
+1,146
| New | +$212K | 0.01% | 301 |
|
|
2018
Q1 | – | Sell |
-1,182
| Closed | -$239K | – | 367 |
|
|
2017
Q4 | $239K | Sell |
1,182
-2
| -0.2% | -$398 | 0.01% | 308 |
|
|
2017
Q3 | $221K | Buy |
+1,184
| New | +$211K | 0.01% | 331 |
|
Other funds holding CI
LMFP
MIHAS
WAM
AAMU
CGH
P
Ballentine Partners's CI Position: Q2 2026 in Review
Ballentine Partners increased its Cigna (CI) stake by 31% in Q2 2026, buying an estimated $445K and bringing the position to 6,703 shares worth $1.85M. The position accounts for 0.02% of the portfolio, ranked #240.
Ballentine Partners first reported a position in CI in Q3 2017 and has held it in 34 quarters since. The position peaked at $3.12M in Q2 2025. 256 funds tracked by Wall St. Rank hold CI as of Q2 2026.
- Ballentine Partners held 6,703 shares of Cigna worth $1.85M as of Q2 2026.
- Ballentine Partners bought 1,575 Cigna shares in Q2 2026, an estimated $445K.
- Cigna made up 0.02% of Ballentine Partners's portfolio in Q2 2026, its #240 holding.
- Ballentine Partners first reported a position in Cigna in Q3 2017 and has held it in 34 quarters since.
- Ballentine Partners's Cigna position peaked at $3.12M in Q2 2025.
- 256 funds tracked by Wall St. Rank held Cigna as of Q2 2026.
Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.